Cita APA

Cicin, I., Plimack, E. R., Gurney, H., Leibowitz, R., Alekseev, B. Y., Parnis, F. X., . . . Sternberg, C. N. (2024). Epacadostat plus pembrolizumab versus placebo plus pembrolizumab for advanced urothelial carcinoma: Results from the randomized phase III ECHO-303/KEYNOTE-698 study.

Citación estilo Chicago

Cicin, Irfan, et al. Epacadostat Plus Pembrolizumab Versus Placebo Plus Pembrolizumab for Advanced Urothelial Carcinoma: Results From the Randomized Phase III ECHO-303/KEYNOTE-698 Study. 2024.

Cita MLA

Cicin, Irfan, et al. Epacadostat Plus Pembrolizumab Versus Placebo Plus Pembrolizumab for Advanced Urothelial Carcinoma: Results From the Randomized Phase III ECHO-303/KEYNOTE-698 Study. 2024.